Special Issue Call for Papers

American Journal of Infectious Diseases and Microbiology

Special Issue Call for Papers

Special Issue on Viral infection prevention and treatment by natural means

To investigate the efficacy of herbal, dietary, complementary, and natural therapies in prevention and treatment of viral infection. Respiratory viruses are a major cause of influenza-like illness (ILI) symptoms in children and adults, leading to substantial morbidity and mortality each year. Several herbal therapies were used for prevention and treatment viral respiratory illnesses. There is scientific evidence about several complementary health practices for colds. Zinc taken orally (by mouth) may reduce the length and severity of a cold. For most people, taking vitamin C supplements on a regular basis only slightly reduces the length and severity of colds and does not reduce the number of colds that they catch. Probiotics were found better than placebo in reducing the number of participants experiencing episodes of acute URTIs, the rate ratio of episodes of acute URTI and reducing antibiotic use. This indicates that probiotics may be more beneficial than placebo for preventing acute URTIs. Diarrhea associated with rotavirus is one of the major gastrointestinal problems faced by human infants. The protective effectiveness of probiotic feeding against naturally acquired diarrhea is also under investigation. Alkanization of blood by diet or naturally may prevent or cure influenza. Disintegration of influenza A, B and C virion appeared to depend on pH level of the medium. Diet and drinking water play important role in the pH level of blood. In a slightly alkaline environment viruses might be weakened or do not multiply efficiently. Immune function may work better in alkaline medium as well. Earthing is another natural anti-inflammatory and antioxidant source for human body. It is now accepted that an overwhelming inflammatory response is the cause of human deaths from avian H5N1 influenza infection. Earthing accelerated immune response following vaccination, as demonstrated by increases of gamma globulin concentration.

About the issue

The scope of topics covered in the this issue include:

  • 1. Prevention and treatment of viral infection
  • 2. Effect of blood alkanization on viral infection

Important dates

Submission Deadline: December 31, 2015
Notification of Acceptance: January 31, 2016
Final Version Due: February, 2016
Special Issue Publishing Date: March, 2016

Chief Guest Editor

Haider Abdul-Lateef Mousa
College of Medicine, University of Basrah, Iraq
Email: haideramousa@hotmail.com

Submit your article now

Manuscripts should be submitted as an attached file to an e-mail directed to the Chief Guest Editor, Haider Abdul-Lateef Mousa at the address: <haideramousa@hotmail.com>

Special Issue on Emerging Role of Disease Biomarker

Over the past decade, biomarker discovery has generated a huge impact in disease diagnosis, prognosis and therapy. The “Omics” storm has helped in the identification of many biomarkers of interest. Most of these biomarkers have clinical importance. This special issue will focus mainly on the identification and validation of gene or protein-based biomarker in human diseases and their clinical applications. Considering the huge burden of Infectious and non-communicable diseases worldwide, it becomes all the more essential to analyze the existing knowledge regarding the emerging role of disease biomarker and their subsequent impact in our society. Disease biomarker can not only play critical roles in clinical application but also in drug discovery and development. Taken together, this issue aims to publish articles related to biomarker discovery, their impact in controlling massive disease outbreaks as also biomarkers associated with early disease diagnosis and monitoring of disease severity as well as patient response to therapies and finally the evaluation of these biomarkers in clinical trials.

About the issue

The scope of topics covered in the this issue include:

  • Clinical application of Infectious disease biomarkers
  • Genomic and proteomic technologies in Infectious disease biomarker discovery
  • Genomic biomarkers in health and disease
  • Potential biomarkers in infectious diseases and cancer therapeutics

Important dates

Submission Deadline: December 31, 2015
Notification of Acceptance: February 29, 2016
Final Version Due: March, 2016
Special Issue Publishing Date: April, 2016

Chief Guest Editor

Dr. Sumi Mukhopadhyay
Calcutta School of Tropical Medicine, India
Email: drsumimukhopadhyay@gmail.com

Guest Editor

Dr. Swarnali Acharyya
Institute for Cancer Genetics, College of Physicians and Surgeons, Columbia University, New York
Email: swarnali@hotmail.com

Dr. Srikanta Goswami
National Institute of Biomedical Genomics
Email: srikanta_gs@hotmail.com

Dr. Anil Kumar Chava
Walgreens, Henderson, KY
Email: anilkumar.chava@gmail.com

Submit your article now

Manuscripts should be submitted as an attached file to an e-mail directed to the Chief Guest Editor, Dr. Sumi Mukhopadhyay at the address: <drsumimukhopadhyay@gmail.com>

Special Issue on Ebola virus: a global threat

Ebola virus is the most dangerous of the five known viruses within the genus Ebolavirus. The Ebola outbreak in West Africa is the world's deadliest to date and the World Health Organization has declared an international health emergency as more than 2,100 people have died of the virus in Guinea, Liberia, Sierra Leone and Nigeria this year. Thus, the aim of this issue is to create public awareness by describing the basic features of the virus, its epidemiology and global response to Ebola outbreaks. Moreover, it will give readers a brief insight on the current strategies to diagnosis, treatment, and prevention of the disease. Therefore, this issue will be focused on the epidemiology and its global response to Ebola outbreaks, and current strategies to the diagnosis, treatment, prevention and control.

About the issue

The scope of topics covered in the this issue include:

  • What is Ebola virus?
  • Epidemiology
  • Global response to Ebola outbreaks
  • Current strategies to diagnosis, treatment, prevention and control

Important dates

Submission Deadline: October 20, 2014
Notification of Acceptance: November 20, 2014
Final Version Due: November 30, 2014
Special Issue Publishing Date: December 30, 2014

Chief Guest Editor

Tewelde Tesfaye
Department of Medical Microbiology and Immunology, Institute of Biomedical Sciences, College of Health Sciences, Mekelle University, Ethiopia
Email: ttesfayg@gmail.com

Guest Editor

Getenet Beyene
Department of Medical Laboratory Science and Pathology, College of Health and Medical Sciences, Jimma University, Ethiopia
Email: rgetenet@yahoo.com

Saravanan Muthupandian
Department of Medical Microbiology and Immunology, Institute of Biomedical Sciences, College of Health Sciences, Mekelle University, Ethiopia
Email: bioinfosaran@gmail.com

Submit your article now

Manuscripts should be submitted as an attached file to an e-mail directed to the Chief Guest Editor, Tewelde Tesfaye at the address: <ttesfayg@gmail.com>